Literature DB >> 25999227

Chronic Lyme disease.

Paul M Lantos1.   

Abstract

Chronic Lyme disease is a poorly defined diagnosis that is usually given to patients with prolonged, unexplained symptoms or with alternative medical diagnoses. Data do not support the proposition that chronic, treatment-refractory infection with Borrelia burgdorferi is responsible for the many conditions that get labeled as chronic Lyme disease. Prolonged symptoms after successful treatment of Lyme disease are uncommon, but in rare cases may be severe. Prolonged courses of antibiotics neither prevent nor ameliorate these symptoms and are associated with considerable harm.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antibiotics; Borrelia burgdorferi; Chronic Lyme disease; Chronic fatigue; Chronic pain; Lyme disease

Mesh:

Substances:

Year:  2015        PMID: 25999227      PMCID: PMC4477530          DOI: 10.1016/j.idc.2015.02.006

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  107 in total

1.  Culture Borrelia burgdorferi.

Authors:  R C Tilton; D Barden; M Sand
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

2.  'Rare' infections mimicking multiple sclerosis: consider Lyme disease.

Authors:  Raphael B Stricker; Lorraine Johnson
Journal:  Clin Neurol Neurosurg       Date:  2010-12-18       Impact factor: 1.876

3.  Final report of the Lyme disease review panel of the Infectious Diseases Society of America.

Authors:  Paul M Lantos; William A Charini; Gerald Medoff; Manuel H Moro; David M Mushatt; Jeffrey Parsonnet; John W Sanders; Carol J Baker
Journal:  Clin Infect Dis       Date:  2010-07-01       Impact factor: 9.079

4.  Treatment of the early manifestations of Lyme disease.

Authors:  A C Steere; G J Hutchinson; D W Rahn; L H Sigal; J E Craft; E T DeSanna; S E Malawista
Journal:  Ann Intern Med       Date:  1983-07       Impact factor: 25.391

5.  Management of tick bites and early Lyme disease: a survey of Connecticut physicians.

Authors:  T Murray; H M Feder
Journal:  Pediatrics       Date:  2001-12       Impact factor: 7.124

6.  Lyme disease associated with fibromyalgia.

Authors:  H Dinerman; A C Steere
Journal:  Ann Intern Med       Date:  1992-08-15       Impact factor: 25.391

7.  Summary of the first 100 patients seen at a Lyme disease referral center.

Authors:  L H Sigal
Journal:  Am J Med       Date:  1990-06       Impact factor: 4.965

8.  Cognitive function in post-treatment Lyme disease: do additional antibiotics help?

Authors:  R F Kaplan; R P Trevino; G M Johnson; L Levy; R Dornbush; L T Hu; J Evans; A Weinstein; C H Schmid; M S Klempner
Journal:  Neurology       Date:  2003-06-24       Impact factor: 9.910

9.  Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  J J Halperin; E D Shapiro; E Logigian; A L Belman; L Dotevall; G P Wormser; L Krupp; G Gronseth; C T Bever
Journal:  Neurology       Date:  2007-05-23       Impact factor: 9.910

Review 10.  Lyme disease: an infectious and postinfectious syndrome.

Authors:  E S Asch; D I Bujak; M Weiss; M G Peterson; A Weinstein
Journal:  J Rheumatol       Date:  1994-03       Impact factor: 4.666

View more
  29 in total

1.  Association of Seropositivity to Borrelia burgdorferi With the Risk of Neuropsychiatric Disorders and Functional Decline in Older Adults: The Aging Multidisciplinary Investigation Study.

Authors:  Virgilio Hernández Ruiz; Arlette Edjolo; Claire Roubaud-Baudron; Benoît Jaulhac; José-Alberto Avila-Funes; Jean-François Dartigues; Hélène Amieva; Karine Pérès
Journal:  JAMA Neurol       Date:  2020-02-01       Impact factor: 18.302

Review 2.  ["Choosing wisely" in infectious diseases : Overuse of antibiotics - too few vaccinations].

Authors:  N Jung; H Koop; R Riessen; J-C Galle; B Jany; E Märker-Hermann
Journal:  Internist (Berl)       Date:  2016-06       Impact factor: 0.743

3.  Antibody Response to Lyme Disease Spirochetes in the Context of VlsE-Mediated Immune Evasion.

Authors:  Artem S Rogovskyy; David C Gillis; Yurij Ionov; Ekaterina Gerasimov; Alex Zelikovsky
Journal:  Infect Immun       Date:  2016-12-29       Impact factor: 3.441

Review 4.  Challenges in the Diagnosis and Treatment of Lyme Disease.

Authors:  Robert T Schoen
Journal:  Curr Rheumatol Rep       Date:  2020-01-07       Impact factor: 4.592

5.  Delineating Surface Epitopes of Lyme Disease Pathogen Targeted by Highly Protective Antibodies of New Zealand White Rabbits.

Authors:  Artem S Rogovskyy; Salvador Eugenio C Caoili; Yurij Ionov; Helen Piontkivska; Pavel Skums; Viachaslau Tsyvina; Alex Zelikovsky; Suryakant D Waghela
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

6.  New Zealand White Rabbits Effectively Clear Borrelia burgdorferi B31 despite the Bacterium's Functional vlsE Antigenic Variation System.

Authors:  Maliha Batool; Andrew E Hillhouse; Yurij Ionov; Kelli J Kochan; Fatemeh Mohebbi; George Stoica; David W Threadgill; Alex Zelikovsky; Suryakant D Waghela; Dominique J Wiener; Artem S Rogovskyy
Journal:  Infect Immun       Date:  2019-06-20       Impact factor: 3.441

7.  Lyme Disease in Humans.

Authors:  Justin D Radolf; Klemen Strle; Jacob E Lemieux; Franc Strle
Journal:  Curr Issues Mol Biol       Date:  2020-12-11       Impact factor: 2.081

8.  The HUMTICK study: protocol for a prospective cohort study on post-treatment Lyme disease syndrome and the disease and cost burden of Lyme borreliosis in Belgium.

Authors:  Laurence Geebelen; Tinne Lernout; Benoît Kabamba-Mukadi; Veroniek Saegeman; Hein Sprong; Steven Van Gucht; Philippe Beutels; Niko Speybroeck; Katrien Tersago
Journal:  Arch Public Health       Date:  2017-08-07

9.  The Position of His-Tag in Recombinant OspC and Application of Various Adjuvants Affects the Intensity and Quality of Specific Antibody Response after Immunization of Experimental Mice.

Authors:  Michal Krupka; Josef Masek; Lucia Barkocziova; Pavlina Turanek Knotigova; Pavel Kulich; Jana Plockova; Robert Lukac; Eliska Bartheldyova; Stepan Koudelka; Radka Chaloupkova; Marek Sebela; Daniel Zyka; Ladislav Droz; Roman Effenberg; Miroslav Ledvina; Andrew D Miller; Jaroslav Turanek; Milan Raska
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

10.  Transplantation of Human Embryonic Stem Cells in Patients with Multiple Sclerosis and Lyme Disease.

Authors:  Geeta Shroff
Journal:  Am J Case Rep       Date:  2016-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.